Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(14):1054-1055; doi:10.1093/jnci/96.14.1054
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by McNeil, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeil, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

Early-Stage Lung Cancer Findings End a Debate, Put Focus on Next Steps

Caroline McNeil

The first 10% of the full text of this article appears below.

New data have resolved one of oncology's long-standing debates: Adjuvant therapy in early-stage, non–small-cell lung cancer (NSCLC) does improve survival significantly and probably should become the standard of care, according to the findings of two major trials.

In one of the trials, led by the National Cancer Institute of Canada (NCIC), there was an absolute survival benefit of 15% after 5 years for patients receiving chemotherapy. In the other, led by the Cancer and Leukemia Group B (CALGB), the absolute benefit was 12% after 4 years.

"Our belief is that the findings will lead to changes in therapy," said Bruce Johnson, M.D., of Dana-Farber Cancer Institute, Boston, speaking at the June meeting of the American Society of Clinical Oncology (ASCO) in New Orleans, where the late-breaking abstracts were presented.

Katherine Pisters, M.D., . . . [Full Text of this Article]

Why the Difference?

Next Steps


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?